PEDIATRICS Vol. 60 No. 6 December 1977, pp. 908-912
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barry, D. M. J.
Right arrow Articles by Reeve, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barry, D. M. J.
Right arrow Articles by Reeve, A. W.

Increased Incidence of Gram-Negative Neonatal Sepsis With Intramuscular Iron Administration

D. M. J. Barry MB.Ch.B., M.R.C.P., F.R.A.C.P., D.C.H.1 and A. W. Reeve MB.Ch.B., M.R.A.C.P.1

1 Department of Paediatrics, Hawke's Bay Hospital Board, Memorial Hospital, Hastings, New Zealand

During a five-year period the incidence of neonatal sepsis was 20 times higher in Polynesian newborns compared with European newborns (11 per 1,000 vs. 0.6 per 1,000 total births). This high incidence in Polynesians was confined to a period when the infants were being given intramuscular iron dextran. When the iron administration was stopped the incidence of disease in Polynesians decreased from 17 per 1,000 to 2.7 per 1,000 total births.

An analysis of the Polynesian iron-treated and non-iron-treated groups showed a statistically significant difference in the incidence of sepsis, the type of causative organism, and mortality.

The data suggest that the iron dextran injections have impaired the immunity of the treated infants, making them more susceptible to Escherichia coli sepsis.

Submitted on January 3, 1977
Accepted on October 5, 1977




This article has been cited by other articles:


Home page
 J. Nutr.Home page
C. P. Doherty
Host-Pathogen Interactions: The Role of Iron
J. Nutr., May 1, 2007; 137(5): 1341 - 1344.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
T. A. Markel, P. R. Crisostomo, M. Wang, C. M. Herring, K. K. Meldrum, K. D. Lillemoe, and D. R. Meldrum
The struggle for iron: gastrointestinal microbes modulate the host immune response during infection
J. Leukoc. Biol., February 1, 2007; 81(2): 393 - 400.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
C R Wall, C C Grant, N Taua, C Wilson, and J M D Thompson
Milk versus medicine for the treatment of iron deficiency anaemia in hospitalised infants
Arch. Dis. Child., October 1, 2005; 90(10): 1033 - 1038.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
S. Sankaranarayanan, J. Untoro, J. Erhardt, R. Gross, and F. J. Rosales
Daily Iron Alone but Not in Combination with Multimicronutrients Increases Plasma Ferritin Concentrations in Indonesian Infants with Inflammation
J. Nutr., August 1, 2004; 134(8): 1916 - 1922.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. N. Raymond, E. A. Dertz, and S. S. Kim
Bioinorganic Chemistry Special Feature: Enterobactin: An archetype for microbial iron transport
PNAS, April 1, 2003; 100(7): 3584 - 3588.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. K. Ohls, R. A. Ehrenkranz, L. L. Wright, J. A. Lemons, S. B. Korones, B. J. Stoll, A. R. Stark, S. Shankaran, E. F. Donovan, N. C. Close, et al.
Effects of Early Erythropoietin Therapy on the Transfusion Requirements of Preterm Infants Below 1250 Grams Birth Weight: A Multicenter, Randomized, Controlled Trial
Pediatrics, October 1, 2001; 108(4): 934 - 942.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
S. J. Oppenheimer
Iron and Its Relation to Immunity and Infectious Disease
J. Nutr., February 1, 2001; 131(2): 616S - 635.
[Abstract] [Full Text]

Home page
 PediatricsHome page
A. Singhal, R. Morley, R. Abbott, S. Fairweather-Tait, T. Stephenson, and A. Lucas
Clinical Safety of Iron-Fortified Formulas
Pediatrics, March 1, 2000; 105(3): 38e - 38.
[Abstract] [Full Text]